Nemorubicin
|
N648904-50mg
|
≥95% |
108852-90-0 |
50mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
Nemorubicin
|
N648904-25mg
|
≥95% |
108852-90-0 |
25mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
Nemorubicin
|
N648904-10mg
|
≥95% |
108852-90-0 |
10mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
β-Neo-Endorphin
|
N648894-5mg
|
≥98% |
77739-21-0 |
5mg
|
¥ 1400.9
|
期货,请咨询 |
阿拉丁 |
β-Neo-Endorphin
|
N648894-1mg
|
≥98% |
77739-21-0 |
1mg
|
¥ 550.9
|
期货,请咨询 |
阿拉丁 |
β-Neo-Endorphin
|
N648894-10mg
|
≥98% |
77739-21-0 |
10mg
|
¥ 2250.9
|
期货,请咨询 |
阿拉丁 |
N-[(4-Aminophenyl)methyl]adenosine
|
N648877-5mg
|
≥98% |
95523-13-0 |
5mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
N-[(4-Aminophenyl)methyl]adenosine
|
N648877-50mg
|
≥98% |
95523-13-0 |
50mg
|
¥ 11250.9
|
期货,请咨询 |
阿拉丁 |
N-[(4-Aminophenyl)methyl]adenosine
|
N648877-10mg
|
≥98% |
95523-13-0 |
10mg
|
¥ 3750.9
|
期货,请咨询 |
阿拉丁 |
N-acetyl Dapsone-d4
|
N648857-5mg
|
≥98% |
2070015-08-4 |
5mg
|
¥ 10500.9
|
期货,请咨询 |
阿拉丁 |
N-acetyl Dapsone-d4
|
N648857-1mg
|
≥98% |
2070015-08-4 |
1mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
Nitecapone
|
N648818-5mg
|
≥99% |
116313-94-1 |
5mg
|
¥ 2900.9
|
期货,请咨询 |
阿拉丁 |
Nitecapone
|
N648818-25mg
|
≥99% |
116313-94-1 |
25mg
|
¥ 8700.9
|
期货,请咨询 |
阿拉丁 |
Nitecapone
|
N648818-1mg
|
≥99% |
116313-94-1 |
1mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
Nitecapone
|
N648818-10mg
|
≥99% |
116313-94-1 |
10mg
|
¥ 4600.9
|
期货,请咨询 |
阿拉丁 |
Norwogonin
|
N648786-5mg
|
≥99% |
4443-09-8 |
5mg
|
¥ 3150.9
|
期货,请咨询 |
阿拉丁 |
Norwogonin
|
N648786-1mg
|
≥99% |
4443-09-8 |
1mg
|
¥ 1250.9
|
期货,请咨询 |
阿拉丁 |
NHE3-IN-2
|
N648741-50mg
|
≥95% |
92434-13-4 |
50mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
NHE3-IN-2
|
N648741-25mg
|
≥95% |
92434-13-4 |
25mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
NHE3-IN-2
|
N648741-10mg
|
≥95% |
92434-13-4 |
10mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
NHE3-IN-2
|
N648741-100mg
|
≥95% |
92434-13-4 |
100mg
|
¥ 3800.9
|
期货,请咨询 |
阿拉丁 |
NPPM 6748-481
|
N648714-5mg
|
≥99% |
432020-20-7 |
5mg
|
¥ 350.9
|
期货,请咨询 |
阿拉丁 |
NPPM 6748-481
|
N648714-50mg
|
≥99% |
432020-20-7 |
50mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
NPPM 6748-481
|
N648714-25mg
|
≥99% |
432020-20-7 |
25mg
|
¥ 700.9
|
期货,请咨询 |
阿拉丁 |